Suchergebnisse - "Whisenant, Jonathan"

PubPharm (42)

1

A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)

enthalten in: BMC research notes | 2023

von Gumbleton, M. | Allan, S. | Conway, H. | +8

2

A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)

enthalten in: BMC Research Notes | 2023

von Gumbleton, M. | Allan, S. | Conway, H. | +8

3

A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)

enthalten in: BMC Research Notes | 2023

von Gumbleton, M. | Allan, S. | Conway, H. | +8

4

Synthetic helical peptide capping strategies

enthalten in: Chemical Society reviews | 2022

von Whisenant, J. | Burgess, K.

5

Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation : The Phase 3 Randomized Clinical ClarIDHy Trial

enthalten in: JAMA oncology | 2021

von Zhu, A. | Macarulla, T. | Javle, M. | +24

6

Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to Entrectinib

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2021

von Florou, V. | Nevala-Plagemann, C. | Whisenant, J. | +3

7

Guidelines for Management of Urgent Symptoms in Patients with Cholangiocarcinoma and Biliary Stents or Catheters using the Modified RAND/UCLA Delphi Process

enthalten in: Cancers | 2020

von Iyer, R. | Acquisto, S. | Bridgewater, J. | +14

8

Blocking Coronavirus 19 Infection via the SARS-CoV-2 Spike Protein : Initial Steps

enthalten in: ACS medicinal chemistry letters | 2020

von Whisenant, J. | Burgess, K.

9

Unconventional Secondary Structure Mimics : Ladder-Rungs

enthalten in: Angewandte Chemie (International ed. in English) | 2020

von Lin, C. | Arancillo, M. | Whisenant, J. | +1

10

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy) : a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

enthalten in: The Lancet. Oncology | 2020

von Abou-Alfa, G. | Macarulla, T. | Javle, M. | +23

CommentIn: Lancet Oncol. 2020 Jun;21(6):738-739. - PMID 32416071

1
2
3
4
5
Nächster »
[5]